- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06209684
Carbofix Pedicle Screw System: Evaluation of the Clinical and Radiographic Outcomes of the Use of a Carbon Fiber Device Compared to Titanium Devices in Patients Undergoing Spinal Arthrodesis for Degenerative Spinal Diseases
Carbofix Pedicle Screw System: Randomized Clinical Trial to Evaluate the Clinical and Radiographic Outcomes of the Use of a Carbon Fiber Device Compared to Titanium Devices in Patients Undergoing Spinal Arthrodesis for Degenerative Spinal Diseases
Previous clinical study carried out on cancer patients at IOR Spine Surgery (approved in October 2014). The carbon device is indicated in patients suffering from vertebral tumors who need stabilization and will then carry out radiotherapy, because carbon has a practically zero level of interference with ionizing radiation. Carbon also allows for better visualization of the implants on MRI/CT and X-ray. There are no studies in the literature analyzing the use of carbon fiber devices in lumbar degenerative pathologies.
118 patients suffering from degenerative spinal pathology requiring 1 or 2 levels of lumbar or lumbosacral fusion will be valutated.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alessandro Gasbarrini, MD
- Phone Number: 130 0516366
- Email: alessandro.gasbarrini@ior.it
Study Contact Backup
- Name: Cristiana Griffoni, PhD
- Phone Number: 130 0516366
- Email: cristiana.griffoni@ior.it
Study Locations
-
-
-
Bologna, Italy, 40136
- Recruiting
- Istituto Ortopedico Rizzoli
-
Principal Investigator:
- Alessandro Gasbarrini, MD
-
Contact:
- Alessandro Gasbarrini, MD
- Email: alessandro.gasbarrini@ior.it
-
Contact:
- Cristiana Griffoni, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients suffering from degenerative spinal pathology or spondylolisthesis who require instrumented stabilization on 1-2 levels;
- Age greater than or equal to 18 years;
- Ability to understand and sign the informed consent to the study and to follow the required follow-ups.
Exclusion Criteria:
- Metabolic bone disease.
- History of Paget's disease or other osteodystrophies, whether acquired or congenital, including renal osteodystrophy, hyperthyroidism, hypothyroidism, Ehlers-Danlos syndrome, osteogenesis imperfecta, achondroplasia.
- Neoplastic disease.
- History of mental disorder or current psychiatric treatment.
- Pregnancy.
- Immunodeficiency diseases.
- Infectious bone disease (discitis, osteomyelitis)
- Treatment with drugs that can interfere with bone metabolism
- Inability to understand and sign the informed consent to the study and to follow the required follow-up visits.
- Alcohol and/or drug abuse
- Obesity
- Metal allergy
- Participation in other studies on drugs or devices (within 30 days)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental
CarboFix implant for spinal surgery
|
Spinal stabilization using CarboFix screws and rods
|
|
Active Comparator: Traditional
Titanium implant for spinal surgery
|
Spinal stabilization using titanium screws and rods
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fusion rate
Time Frame: through study completion, an average of 1 year
|
Fusion rate after 12 months as demonstrated by computed tomography scan (CT scan). The CT scan will be evaluated by Brantigan scale. |
through study completion, an average of 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Classification system of surgical complications specific for spine
Time Frame: at baseline (day 0)
|
rate of intra-operative complications evaluated by SAVES classification system specific for spine
|
at baseline (day 0)
|
|
Classification system of surgical complications specific for spine
Time Frame: up to 12 months
|
rate of post-operative complications evaluated by SAVES classification system specific for spine
|
up to 12 months
|
|
Visual Analogue Scale
Time Frame: at baseline (day 0)
|
A Visual Analogue Scale (VAS) is one of the pain rating scales used for the first time in 1921 by Hayes and Patterson.
It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.
|
at baseline (day 0)
|
|
Visual Analogue Scale
Time Frame: after 12 months
|
A Visual Analogue Scale (VAS) is one of the pain rating scales used for the first time in 1921 by Hayes and Patterson.
It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.
|
after 12 months
|
|
Visual Analogue Scale
Time Frame: after 3 months
|
A Visual Analogue Scale (VAS) is one of the pain rating scales used for the first time in 1921 by Hayes and Patterson.
It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.
|
after 3 months
|
|
Visual Analogue Scale
Time Frame: after 6 months
|
A Visual Analogue Scale (VAS) is one of the pain rating scales used for the first time in 1921 by Hayes and Patterson.
It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms.
|
after 6 months
|
|
Oswestry Disability Index
Time Frame: at baseline (day 0)
|
The Oswestry Disability Index (ODI) is a self-administered and validated questionnaire in Italian which aims to evaluate disabilities in subjects suffering from low back pain in both the acute and chronic phases.
|
at baseline (day 0)
|
|
Oswestry Disability Index
Time Frame: after 12 months
|
The Oswestry Disability Index (ODI) is a self-administered and validated questionnaire in Italian which aims to evaluate disabilities in subjects suffering from low back pain in both the acute and chronic phases.
|
after 12 months
|
|
Oswestry Disability Index
Time Frame: after 3 months
|
The Oswestry Disability Index (ODI) is a self-administered and validated questionnaire in Italian which aims to evaluate disabilities in subjects suffering from low back pain in both the acute and chronic phases.
|
after 3 months
|
|
Oswestry Disability Index
Time Frame: after 6 months
|
The Oswestry Disability Index (ODI) is a self-administered and validated questionnaire in Italian which aims to evaluate disabilities in subjects suffering from low back pain in both the acute and chronic phases.
|
after 6 months
|
|
EuroQoL-5D
Time Frame: at baseline (day 0)
|
EQ-5D is a standardised measure of health-related quality of life developed by the EuroQol Group to provide a simple, generic questionnaire for use in clinical and economic appraisal and population health surveys.
EQ-5D assesses health status in terms of five dimensions of health and is considered a 'generic' questionnaire because these dimensions are not specific to any one patient group or health condition
|
at baseline (day 0)
|
|
EuroQoL-5D
Time Frame: after 12 months
|
EQ-5D is a standardised measure of health-related quality of life developed by the EuroQol Group to provide a simple, generic questionnaire for use in clinical and economic appraisal and population health surveys.
EQ-5D assesses health status in terms of five dimensions of health and is considered a 'generic' questionnaire because these dimensions are not specific to any one patient group or health condition
|
after 12 months
|
|
EuroQoL-5D
Time Frame: after 3 months
|
EQ-5D is a standardised measure of health-related quality of life developed by the EuroQol Group to provide a simple, generic questionnaire for use in clinical and economic appraisal and population health surveys.
EQ-5D assesses health status in terms of five dimensions of health and is considered a 'generic' questionnaire because these dimensions are not specific to any one patient group or health condition
|
after 3 months
|
|
EuroQoL-5D
Time Frame: after 6 months
|
EQ-5D is a standardised measure of health-related quality of life developed by the EuroQol Group to provide a simple, generic questionnaire for use in clinical and economic appraisal and population health surveys.
EQ-5D assesses health status in terms of five dimensions of health and is considered a 'generic' questionnaire because these dimensions are not specific to any one patient group or health condition
|
after 6 months
|
|
Short Form-12
Time Frame: at baseline (day 0)
|
The SF-12 is composed of 12 items (derived from the 36 of the original SF-36 questionnaire) which produce two measures relating to two different aspects of health: physical health and mental health. The SF-12 is made up of 4 scales (physical functioning, role and physical health, role and emotional state, mental health) measured by 2 items each and 4 scales each measured by one item (physical pain, vitality, social activities and general health). |
at baseline (day 0)
|
|
Short Form-12
Time Frame: after 12 months
|
The SF-12 is composed of 12 items (derived from the 36 of the original SF-36 questionnaire) which produce two measures relating to two different aspects of health: physical health and mental health. The SF-12 is made up of 4 scales (physical functioning, role and physical health, role and emotional state, mental health) measured by 2 items each and 4 scales each measured by one item (physical pain, vitality, social activities and general health). |
after 12 months
|
|
Short Form-12
Time Frame: after 3 months
|
The SF-12 is composed of 12 items (derived from the 36 of the original SF-36 questionnaire) which produce two measures relating to two different aspects of health: physical health and mental health. The SF-12 is made up of 4 scales (physical functioning, role and physical health, role and emotional state, mental health) measured by 2 items each and 4 scales each measured by one item (physical pain, vitality, social activities and general health). |
after 3 months
|
|
Short Form-12
Time Frame: after 6 months
|
The SF-12 is composed of 12 items (derived from the 36 of the original SF-36 questionnaire) which produce two measures relating to two different aspects of health: physical health and mental health. The SF-12 is made up of 4 scales (physical functioning, role and physical health, role and emotional state, mental health) measured by 2 items each and 4 scales each measured by one item (physical pain, vitality, social activities and general health). |
after 6 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Boriani S, Tedesco G, Ming L, Ghermandi R, Amichetti M, Fossati P, Krengli M, Mavilla L, Gasbarrini A. Carbon-fiber-reinforced PEEK fixation system in the treatment of spine tumors: a preliminary report. Eur Spine J. 2018 Apr;27(4):874-881. doi: 10.1007/s00586-017-5258-5. Epub 2017 Aug 16.
- Boriani S, Pipola V, Cecchinato R, Ghermandi R, Tedesco G, Fiore MR, Dionisi F, Gasbarrini A. Composite PEEK/carbon fiber rods in the treatment for bone tumors of the cervical spine: a case series. Eur Spine J. 2020 Dec;29(12):3229-3236. doi: 10.1007/s00586-020-06534-0. Epub 2020 Jul 20.
- Vaccaro AR, Garfin SR. Pedicle-Screw Fixation in the Lumbar Spine. J Am Acad Orthop Surg. 1995 Oct;3(5):263-274. doi: 10.5435/00124635-199509000-00002.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Carbofix degenerative
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Degenerative Disc Disease
-
Assistance Publique - Hôpitaux de ParisTerminatedCervical Degenerative Disc Disease | Kyphosis | Lumbar Degenerative Disc DiseaseFrance
-
Centinel SpineAvaniaEnrolling by invitationDegenerative Disc Disease | Symptomatic Cervical Disc Disease | Cervical Spine Degenerative Disc Disease | Cervical Spine Degenerative DiseaseGermany
-
Synergy Spine SolutionsMCRAActive, not recruitingCervical Degenerative Disc DiseaseUnited States
-
Orthofix Inc.TerminatedCervical Degenerative Disc DiseaseUnited States
-
Assiut UniversityNot yet recruiting
-
Spine BioPharma, IncMCRAActive, not recruitingLumbar Degenerative Disc DiseaseUnited States
-
AxioMed Spine CorporationUnknownDegenerative Disc Disease (DDD)United States, Germany
-
Synthes USA HQ, Inc.CompletedLumbar Degenerative Disc Disease
-
DePuy InternationalTerminatedCervical Degenerative Disc DiseaseAustralia, Germany, Italy, Malaysia, Netherlands, Spain, United Kingdom
-
Yuhan CorporationCompletedDisc Degenerative DiseaseKorea, Republic of